Propanc Biopharma, Inc. Common Stock (PPCB) — Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Propanc Biopharma, Inc. Common Stock (PPCB) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($18.73K) in capital expenditures ($4.87). See Propanc Biopharma, Inc. Common Stock (PPCB) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$18.73K
USD

Capital Expenditures

$4.87
USD

Data as of

Dec 2024
Most recent filing

Annual Capital Reinvestment Ratio for Propanc Biopharma, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Propanc Biopharma, Inc. Common Stock from None to None. For live market cap and broader valuation context, see Propanc Biopharma, Inc. Common Stock (PPCB) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow